Mr. Eoin Deegan:

I will go back to a point that has been made a couple of times this evening, which is that at the moment the technology is classified as a GMO technology. We are waiting on a proposal from the European Commission with regard to amending the legislation.

From our point of view, we are constantly looking at options across the spectrum to combat climate change. On this issue, we are looking for solutions to ensure continued protections for health and the environment. There is a balancing act. The issue here is that the technology is classified as a GMO and, as a member of the European Union, we are bound to follow EU directives and manage applications or regulation of CRISPR-Cas9 accordingly.